Parkinson Disease
Showing NaN - NaN of 67
Parkinson Disease Trial in Germany, Spain, United States (Spheramine (BAY86-5280), Placebo)
Terminated
- Parkinson Disease
- Spheramine (BAY86-5280)
- Placebo
-
Birmingham, Alabama
- +14 more
Sep 23, 2015
Parkinson Disease Trial in United States (Placebo, inosine)
Impulse Control Disorders in Parkinson's Patients Treated With
Completed
- Parkinson Disease
-
Gilbert, Arizona
- +48 more
Nov 11, 2013
Parkinson Disease Trial in Canada, United States (NS 2330)
Completed
- Parkinson Disease
- NS 2330
-
Peoria, Arizona
- +54 more
Oct 28, 2013
Parkinson Disease Trial in Canada, United States (Isradipine CR 5mg, Isradipine CR 10mg, Isradipine CR 20mg)
Completed
- Parkinson Disease
- Isradipine CR 5mg
- +3 more
-
Sunnyvale, California
- +19 more
Apr 16, 2013
Parkinson Disease Trial in Canada, United States (Coenzyme Q10 with vitamin E, with vitamin E)
Terminated
- Parkinson Disease
- Coenzyme Q10 with vitamin E
- placebo with vitamin E
-
Birmingham, Alabama
- +67 more
Dec 24, 2012
Parkinson Disease Trial in Canada, Puerto Rico, United States (CEP-1347 10mg, CEP1347 25mg, CEP-1347 50mg)
Terminated
- Parkinson Disease
- CEP-1347 10mg
- +3 more
-
Phoenix, Arizona
- +65 more
May 8, 2012
Parkinson's Research: The Organized Genetics Initiative
Completed
- Parkinson Disease
-
Phoenix, Arizona
- +57 more
Feb 15, 2011
Parkinson Disease, Parkinsonian Syndrome Trial in United States (levodopa, Mirapex (pramipexole), [123I]ß-CIT and SPECT imaging)
Completed
- Parkinson Disease
- Parkinsonian Syndrome
- levodopa
- +2 more
-
Oxnard, California
- +12 more
Sep 28, 2010
PRECEPT Study Cohort
Unknown status
- Parkinson Disease
-
Phoenix, Arizona
- +54 more
Mar 26, 2008